Hagar’s GWave Glucose Monitor Designated an FDA Breakthrough Device

November 29, 2021

The FDA has designated Hagar’s GWave noninvasive continuous glucose monitoring system a breakthrough device.

The GWave device is one-third the size of a smartphone and involves less radiofrequency exposure for users than a smartphone, the Israel-based company said.

The device uses radiofrequency waves to measure glucose levels in the blood without the need for a blood sample.

View today's stories